Key result
Practical doses of n-3 fatty acids fail to reduce coronary thrombosis or MI.
Answers are grounded in this paper and cite their sources.
Studies of Greenland Eskimos showed that a very high intake of marine n-3 fatty acids markedly inhibited platelet reactivity and suggested that intake of these fatty acids might prevent coronary thrombosis. Later studies with lower, more practical doses of n-3 fatty acids also have shown a platelet inhibitory effect of n-3 fatty acids, albeit fairly marginal. Furthermore, n-3 fatty acids have little effect on measures of blood coagulability and may slightly decrease fibrinolysis. In animal models, n-3 fatty acids often have been shown to inhibit thrombosis, but again the doses have tended to be very high. Finally, there has been little effect of (low-dose) n-3 fatty acids in clinical trials in humans on the incidence of myocardial infarction. Overall, there is little evidence for a major antithrombotic effect of practical doses of n-3 fatty acids on coronary thrombosis. This does not exclude a beneficial effect of n-3 fatty acids on coronary heart disease as suggested from clinical trials, but the major effect may be antiarrhythmic rather than antithrombotic.
No takes yet. Share an insight, caveat, or question.
Kristensen et al. (2001) conducted a review in Coronary thrombosis and coronary heart disease. n-3 polyunsaturated fatty acids was evaluated on Coronary thrombosis and myocardial infarction. Practical doses of n-3 polyunsaturated fatty acids show little evidence for a major antithrombotic effect on coronary thrombosis or the incidence of myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: